The estimated Net Worth of Murdo Gordon is at least $23.8 Миллион dollars as of 10 August 2023. Mr. Gordon owns over 9,558 units of AMGEN stock worth over $14,620,754 and over the last 9 years he sold AMGN stock worth over $2,508,306. In addition, he makes $6,655,840 as Executive Vice President of Global Commercial Operations at AMGEN.
Sign up
Mr. Gordon AMGN stock SEC Form 4 insiders trading
Murdo has made over 10 trades of the AMGEN stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 9,558 units of AMGN stock worth $2,508,306 on 10 August 2023.
The largest trade he's ever made was exercising 39,235 units of AMGEN stock on 10 March 2018 worth over $12,946,765. On average, Murdo trades about 2,894 units every 82 days since 2015. As of 10 August 2023 he still owns at least 44,308 units of AMGEN stock.
You can see the complete history of Mr. Gordon stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Murdo Gordon biography
Murdo Gordon serves as Executive Vice President of Global Commercial Operations of the Company. He will assume Hooper’s role, has been Bristol-Myers Squibb’s Chief Commercial Officer since June 2016. In this role he was responsible for commercial strategy across the globe, including all sales and marketing activities, as well as customer operations, access and pricing. Prior to his current role, Gordon served as head of worldwide markets with responsibility for the promotion of all the company’s brands globally. He moved to the U.S. in 2003 where he held senior commercial leadership positions in cardiovascular, neuroscience, oncology and immunology, as well as access and government affairs – all areas of continuing focus and importance for Amgen. Gordon joined Bristol-Myers Squibb in 1989 in Canada, after receiving a Bachelor of Science in Cell and Molecular Biology from Concordia University, Montreal. In addition, he participated in the General Management Program, CEDEP at INSEAD, Fontainebleau, France.
What is the salary of Murdo Gordon?
As the Executive Vice President of Global Commercial Operations of AMGEN, the total compensation of Murdo Gordon at AMGEN is $6,655,840. There are 2 executives at AMGEN getting paid more, with Robert Bradway having the highest compensation of $19,612,800.
How old is Murdo Gordon?
Murdo Gordon is 53, he's been the Executive Vice President of Global Commercial Operations of AMGEN since 2018. There are 21 older and 2 younger executives at AMGEN. The oldest executive at AMGEN Inc. is Fred Hassan, 74, who is the Independent Director.
What's Murdo Gordon's mailing address?
Murdo's mailing address filed with the SEC is ONE AMGEN CENTER DRIVE, , THOUSAND OAKS, CA, 91320.
Insiders trading at AMGEN
Over the last 22 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer и Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.
What does AMGEN do?
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
What does AMGEN's logo look like?
Complete history of Mr. Gordon stock trades at AMGEN и Bristol-Myers Squibb Co
AMGEN executives and stock owners
AMGEN executives and other stock owners filed with the SEC include:
-
Robert Bradway,
Chairman of the Board, President, Chief Executive Officer -
Jonathan Graham,
Senior Vice President, General Counsel, Secretary -
Murdo Gordon,
Executive Vice President of Global Commercial Operations -
David Reese,
Executive Vice President - Research and Development -
Robert A. Bradway,
Chairman, CEO & Pres -
Murdo Gordon,
Exec. VP of Global Commercial Operations -
Dr. David M. Reese M.D.,
Exec. VP of R&D -
Esteban Santos,
Exec. VP of Operations -
Peter H. Griffith,
Exec. VP & CFO -
Robert Eckert,
Lead Independent Director -
Gregory Garland,
Independent Director -
Ronald Sugar,
Independent Director -
Charles Holley,
Independent Director -
Wanda Austin,
Independent Director -
Brian Druker,
Independent Director -
Fred Hassan,
Independent Director -
Robert Williams,
Independent Director -
Tyler Jacks,
Independent Director -
Ellen Kullman,
Independent Director -
Amy Miles,
Independent Director -
Linda Louie,
Vice President - Finance, Chief Accounting Officer -
David Piacquad,
Senior Vice President - Business Development -
Lori Johnston,
Senior Vice President - Human Resources -
Cynthia Patton,
Senior Vice President, Chief Compliance Officer -
Esteban Santos,
Executive Vice President, Operations -
Peter Griffith,
Chief Financial Officer, Executive Vice President -
Nancy A. Grygiel,
Sr. VP of Worldwide Compliance & Bus. Ethics and Chief Compliance Officer -
Jonathan P. Graham,
Exec. VP, Gen. Counsel & Sec. -
Arvind Sood,
VP of Investor Relations -
Mike Zahigian,
Sr. VP & Chief Information Officer -
Linda H. Louie,
VP of Fin. & Chief Accounting Officer -
Annette Louise Such,
CAO -
Frank Biondi,
Director -
Greg C. Garland,
Director -
Frank C Herringer,
Director -
David W Meline,
EVP & CFO -
Anthony C Hooper,
EVP, Global Commercial Ops. -
R Sanders Williams,
Director -
Rebecca M Henderson,
Director -
Judith C Pelham,
Director -
David Baltimore,
Director -
Sean E Harper,
EVP, Research & Development -
Carbonnel Francois De,
Director -
James E. Bradner,
EVP, R&D, & Chief Sci. Officer -
Nancy A. Grygiel,
SVP & CCO -
Thomas James Flanagan,
Sr VP & CIO -
Leonard D Schaeffer,
Director -
Jonathan M Peacock,
CFO -
Gilbert S Omenn,
Director -
J Paul Reason,
Director -
Thomas J.W. Dittrich,
VP, Finance & CAO -
David J Scott,
Sr. VP, Gen. Counsel & Secy. -
A Kelly Michael,
VP Corp Plng & Control & CAO -
Stuart A Tross,
SVP, Human Resources -
Kevin W Sharer,
Chairman of the Bd, CEO & Pres -
Vance D Coffman,
Director -
David W Beier,
SVP Global Govt & Corp Affairs -
Fabrizio Bonanni,
Senior VP, Manufacturing -
Anna Richo,
SVP & CCO -
Jerry D Choate,
Director -
Frederick W Gluck,
Director -
Roger M Perlmutter,
Exec VP Research & Development -
George J Morrow,
Exe VP, Global Commercial Ops -
Brian M Mcnamee,
Sr. V.P. Human Resources -
Richard D Nanula,
Exe VP Fin, Strat & Comm & CFO -
Franklin P Jr Johnson,
Director -
Donald B Rice,
Director -
Dennis M Fenton,
Executive Vice President -
Hassan Dayem,
Sr. V.P. & Chief Info. Officer -
Barry D Schehr,
VP Financial Ops & CAO -
Edward V Fritzky,
Director -
Steven M Odre,
Sr. VP, Gen. Cousel & Secy. -
Timothy O Martin,
V.P., Planning and Control -
Beth C Seidenberg,
Sr VP Development -
Willard H Dere,
Sr. V.P., Global Dev & CMO -
Joseph P Miletich,
Sr VP Rsch & Preclinical Dev -
Patricia C Sueltz,
Director -
Steven Lazarus,
Director -
Derek Miller,
SVP, Human Resources -
Omar Ishrak,
Director -
Rachna Khosla,
SVP, Business Development -
Michael V Drake,
Director -
Matthew C. Busch,
VP, Finance & CAO -
Mary E. Klotman,
Director